Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia

Medical Journal of Australia

Volumn 193, Issue 10, 2010, Pages 572-577

  Smithers, Bernard M ^a   Fahey, Paul P ^b   Corish, Tracie ^b   Gotley, David C ^a   Falk, Gregory L ^c   Smith, Garett S ^d   Kiroff, George K ^e   Clouston, Andrew D ^f   Watson, David I ^g   Whiteman, David C ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c ANZAC Research Institute   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e GEELONG HOSPITAL   (Australia)

^f Envoi Specialist Pathologists ^*  (Australia)

^g FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BARIUM ENEMA; BRONCHOSCOPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; EPIGASTRIC PAIN; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; FEMALE; GASTRO OESOPHAGEAL JUNCTION ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFORMATION RETRIEVAL; LAPAROSCOPY; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ODYNOPHAGIA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; THORAX PAIN; WEIGHT REDUCTION;

EID: 78649650203     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb04064.x     Document Type: Article

References (28)

1. Stavrou EP, McElroy HJ, Baker DF, et al. Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005. Med J Aust 2009; 191: 310-314.
2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
3. Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654. (Pubitemid 30612230)
4. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146. (Pubitemid 40277094)
5. Pandeya N, Webb PM, Sadeghi S, et al. Gastrooesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut 2010; 59: 31-38.
6. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173-180. (Pubitemid 351158042)
7. Pandeya N, Williams GM, Sadhegi S, et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol 2008; 168: 105-114. (Pubitemid 351881885)
8. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150-155.
9. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-890. (Pubitemid 29239582)
10. Mayne ST, Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 2002; 132 (11 Suppl): 3467S-3470S.
11. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92.
12. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
13. Kendall BJ, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus. Gut 2008; 57: 448-454.
14. Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila) 2008; 1: 308-311.
15. Spechler SJ, Dixon MF, Genta R, et al. Adenocarcinoma of the oesophago-gastric junction. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours. Volume 2. Lyon: IARC Press, 2000.
16. Gibbs JF, Rajput A, Chadha KS, et al. The changing profile of esophageal cancer presentation and its implication for diagnosis. J Natl Med Assoc 2007; 99: 620-626. (Pubitemid 47012771)
17. Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999; 94: 86-91. (Pubitemid 29063449)
18. DeMeester TR, Barlow AP. Surgery and current management for cancer of the esophagus and cardia: part I. Curr Probl Surg 1988; 25: 475-531.
19. Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50 Suppl 5: v1-v23.
20. Salavati A, Basu S, Heidari P, Alavi A. Impact of fluorodeoxyglucose PET on the management of esophageal cancer. Nucl Med Commun 2009; 30: 95-116.
21. Cronin-Fenton DP, Mooney MM, Clegg LX, Harlan LC. Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. World J Gastroenterol 2008; 14: 3165-3173.
22. Cronin-Fenton DP, Sharp L, Carsin AE, Comber H. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 2007; 43: 565-575. (Pubitemid 46188525)
23. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467. (Pubitemid 26269945)
24. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
25. Burmeister BH, Denham JW, O'Brien M, et al. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study. Int J Radiat Oncol Biol Phys 1995; 32: 997-1006.
26. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668.
27. Chiu PW, Chan AC, Leung SF, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005; 9: 794-802.
28. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317. (Pubitemid 46218723)